(and for GGT, sex-specific) limits were used. For AST, a cut-off limit of 85 units/l gave 90% 69 specificity and 37% sensitivity; for GGT cut-off limits of 288 units/l in men and 138 units/l in 70 women gave 90% specificity for both and 40% sensitivity in men, 63% sensitivity in women. 
reports on whether serum disialotransferrin (carbohydrate-deficient transferrin, CDT) is 104 affected by liver disease (9) (10) (11) (12) (13) (14) . A number of technical issues, depending on the method used, 105 can affect the validity of CDT results in cirrhosis (15) (16) (17) . Serum GGT, which is cheap and 106 widely available, is a rather non-specific marker of liver damage as well as an index of 107 alcohol intake , and it is increased in a high proportion of people with liver disease. GGT has 108 therefore been discounted for this situation, though there is little information on its potential 109 as an alcohol biomarker in the presence of liver disease. Nor is information readily available 110 about the ability of other commonly available tests to distinguish abstinent from non-111 abstinent patients.
112
We have collected blood samples and clinical information, including alcohol intake history 113 and laboratory test results, from 1578 patients either with liver cirrhosis due to alcohol or 114 with similar alcohol intake but no history or symptoms of liver disease (18) . These data allow 115 us to address the two questions outlined above. First, which tests (including biochemical liver 116 function tests, and haematology tests affected by cirrhosis) are best at distinguishing between 117 those who do or do not have cirrhosis as a result of long-term excessive alcohol intake?
118
Second, can any of these commonly available tests assist in identifying continuing alcohol 119 use among patients with alcoholic liver disease?
120
Information was gathered from patients recruited for the GenomALC Study (18) and USA, mainly from hepatology clinics (for cases, as defined below) and from psychiatric 124 or detoxification facilities for the controls. All participants gave informed consent and the 125 study was approved by appropriate Research Ethics Committees.
126
To be eligible, participants had to have high-risk alcohol intake (greater than 80 grams per 127 day for men, or 50 grams per day for women) for 10 years or more. Cases had alcohol-related 128 cirrhosis, with the diagnosis based on one or more of the following clinical, histological or
129
FibroScan criteria as reported (18) 
141
Control subjects had to meet the alcohol intake criteria with no history or current evidence of Characteristics of 1578 participants who met the eligibility criteria are summarised in Table   146 1.
147
Lifetime alcohol intake estimates were based on participants' recall of habitual daily use of 148 beer, wine, spirits or other alcoholic beverages (converted to grams of alcohol), and of the 149 number of years of high-risk drinking. Current abstinence was assessed by whether the 150 patient reported they had been abstinent from alcohol for 60 days or more before recruitment.
151
Data collection was planned before test and reference standard data were collected.
152
Laboratory test results, as listed in Table 2 illustrate the main effects and interaction, are shown in Figure 1 ; reported abstinence was 177 associated with lower AST and GGT in cases but not in controls (but very few control 178 patients had abstained from alcohol).
179
The ability of the laboratory tests to distinguish cases from controls is summarised in Table 3 .
180
ROC curves (which plot test sensitivity, true positive rate, against (1-specficity), false results for these are shown in more detail in Table 5 and Figure 2 . When data from men and 199 women were analysed together, the AUC for AST was 0.737 and for GGT 0.771. This
200
analysis was then repeated for male and female cases separately (also shown in Table 5 ). For
201
AST, the AUC, test sensitivities and cut-off values were similar in men and women; but for
202
GGT the AUC was greater in women than in men and the appropriate cut-off values
203
(determined by the desired specificity) were substantially higher in men.
204
We have compared the performance of routine tests, and the composite MELD score, for give good discrimination between cases and controls ( continued to show good separation between the case and control groups.
221
The calculated AST/ALT ratio showed better discrimination than either of its components in 222 the case/control comparison (see Table 3 ). The AST/platelet ratio showed no advantages,
223
being significantly worse than platelet count for case/control discrimination or AST for 224 drinking/abstinence (again, see Table 3 ); this is consistent with a previous evaluation (20) . of abstinence specified (60 days or more) may be too short to have made a difference.
247
On the other hand, AST and GGT, which did not perform well for the case-control previously been considered useful in the presence of liver disease. In fact, the test performance (Table 5) for GGT is very similar to that derived from meta-analysis of data 252 from studies on people without liver disease (21) (which estimated GGT sensitivity of 44%
253
and AST sensitivity of 27%, each at 90% specificity). However, the GGT value giving this 254 specificity and sensitivity in our cases (about 250 units/l) is much higher than it would be in 255 alcoholics without known liver disease.
256
Another point to notice is that AST and GGT performed slightly better, both in the case-257 control and abstinent-drinking comparisons, in patients with cirrhosis but no ascites (Table   258 4). This is in contrast to the other tests, and is probably due to decreased liver cell mass in the 259 patients with more advanced disease who have or have had ascites. As these enzymes 260 originate from the liver, very low functioning liver cell mass will lead to less enzyme release 261 into the circulation.
262
For the evaluation of abstinence in individuals with cirrhosis, we found relevant differences showed similar test performance and cut-off limits in men and women ( further investigation.
286
We acknowledge some limitations due to our study design, particularly the existence of 287 spectrum bias because of comparison of extremes rather than unselected patients.
288
Participants were recruited for a case-control genetic association study, so it was important to 
Conclusions

315
We have documented and compared tests related to liver function in alcoholic cirrhosis, and by abstinent/drinking interaction (see Table 2 ). Abstinent/drinking status has significant effects in cases but not in controls. 
